An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis.
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2011
At a glance
- Drugs Tacrolimus (Primary) ; Hydrocortisone
- Indications Inverse psoriasis
- Focus Therapeutic Use
- 24 Jul 2011 New trial record